The application of quinoline-based compounds for the treatment of malaria infections is
hampered by drug resistance. Drug resistance has led to the combination of quinolines with …

Malaria is a vector-and blood-borne infection that is responsible for a large number of
deaths around the world. Most of the currently used antimalarial therapeutics suffer from …

Background Malaria during pregnancy (MiP) results in adverse birth outcomes and poor
maternal health. MiP-related morbidity and mortality is most pronounced in sub-Saharan …

Background Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-
pyrimethamine (SP) is recommended by WHO to prevent malaria in African pregnant …

Abstract Background Malaria caused by Plasmodium falciparum in pregnancy can result in
adverse maternal and fetal sequelae. This review evaluated the adherence of the national …

Introduction: Chemotherapy of malaria has become a rapidly changing field. Less than two
decades ago, treatment regimens were increasingly bound to fail due to emerging drug …

Background Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-
pyrimethamine (SP) is recommended for malaria prevention in HIV-negative pregnant …

Reversing the spread of HIV infection and the incidence of malaria constitute two of the
Millenium Development Goals. However, despite recent achievements, both diseases still …

Malaria continues to be a global health threat, with approximately 247 million cases
worldwide. Despite therapeutic interventions being available, patient compliance is a …

Objective. The antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have
been used for decades to treat rheumatic diseases. CQ is still beneficial for the management …